2017/3 GaBI Journal Table of Contents

Contents

Editor’s Letter

Latest features in GaBI Journal, 2017, Issue 3

Commentary

Patent expiry and costs for anti­cancer medicines for clinical use

Original Research

A survey of Australian prescribers’ views on the naming and substitution of biologicals

Review Article

Biosimilars in Italy: what do real-world data reveal?

Special Report

Physician associations comment on FDA’s interchangeability guidance

Meeting Report

Roundtable on registries: practical considerations for registries – making them work, London, UK, 26 January 2017

Pharmacovigilance, traceability and building trust in biosimilar medicines

Value-added medicines: how repurposed medicines bring value to patients and pharmacists

Abstracted Scientific Content

‘To prescribe generics is to play with the life of the patient’: misconceptions of generics in Guatemala

Research News

Healthcare professionals will accept generic HIV treatments

Source URL: https://gabi-journal.net/20173-gabi-journal-table-of-contents.html